BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33254138)

  • 1. Predicting nonroutine discharge in patients undergoing surgery for vertebral column tumors.
    Ehresman J; Pennington Z; Feghali J; Schilling A; Hersh A; Hung B; Lubelski D; Sciubba DM
    J Neurosurg Spine; 2020 Nov; 34(3):364-373. PubMed ID: 33254138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel online calculator to predict nonroutine discharge, length of stay, readmission, and reoperation in patients undergoing surgery for intramedullary spinal cord tumors.
    Hersh AM; Patel J; Pennington Z; Antar A; Goldsborough E; Porras JL; Feghali J; Elsamadicy AA; Lubelski D; Wolinsky JP; Jallo GI; Gokaslan ZL; Lo SL; Sciubba DM
    Spine J; 2022 Aug; 22(8):1345-1355. PubMed ID: 35342014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of frailty metrics and the Charlson Comorbidity Index for predicting adverse outcomes in patients undergoing surgery for spine metastases.
    Hersh AM; Pennington Z; Hung B; Patel J; Goldsborough E; Schilling A; Feghali J; Antar A; Srivastava S; Botros D; Elsamadicy AA; Lo SL; Sciubba DM
    J Neurosurg Spine; 2022 May; 36(5):849-857. PubMed ID: 34826820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of race on nonroutine discharge, length of stay, and postoperative complications after surgery for spinal metastases.
    Hung B; Pennington Z; Hersh AM; Schilling A; Ehresman J; Patel J; Antar A; Porras JL; Elsamadicy AA; Sciubba DM
    J Neurosurg Spine; 2022 Apr; 36(4):678-685. PubMed ID: 34740176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital Frailty Risk Score and healthcare resource utilization after surgery for metastatic spinal column tumors.
    Elsamadicy AA; Koo AB; Reeves BC; Pennington Z; Yu J; Goodwin CR; Kolb L; Laurans M; Lo SL; Shin JH; Sciubba DM
    J Neurosurg Spine; 2022 Aug; 37(2):241-251. PubMed ID: 35148505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction calculator for nonroutine discharge and length of stay after spine surgery.
    Lubelski D; Ehresman J; Feghali J; Tanenbaum J; Bydon A; Theodore N; Witham T; Sciubba DM
    Spine J; 2020 Jul; 20(7):1154-1158. PubMed ID: 32179154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of nonroutine discharge among patients undergoing surgery for grade I spondylolisthesis: insights from the Quality Outcomes Database.
    Mummaneni PV; Bydon M; Knightly J; Alvi MA; Goyal A; Chan AK; Guan J; Biase M; Strauss A; Glassman S; Foley KT; Slotkin JR; Potts E; Shaffrey M; Shaffrey CI; Haid RW; Fu KM; Wang MY; Park P; Asher AL; Bisson EF
    J Neurosurg Spine; 2019 Dec; 32(4):523-532. PubMed ID: 31812142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical calculator for predicting intraoperative blood loss and transfusion risk in spine tumor patients.
    Pennington Z; Ehresman J; Feghali J; Schilling A; Hersh A; Hung B; Lubelski D; Sciubba DM
    Spine J; 2021 Feb; 21(2):302-311. PubMed ID: 33007469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Outcomes and Health Care Resource Utilization After Surgical Intervention for Metastatic Spinal Column Tumor in Safety-Net Hospitals.
    Elsamadicy AA; Koo AB; David WB; Reeves BC; Sherman JJZ; Craft S; Hersh AM; Duvall J; Lo SL; Shin JH; Mendel E; Sciubba DM
    Spine (Phila Pa 1976); 2023 Jun; 48(11):800-809. PubMed ID: 36972069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for nonroutine discharge in adult spinal deformity surgery.
    Amin RM; Raad M; Jain A; Khashan M; Hassanzadeh H; Frank SM; Kebaish KM
    Spine J; 2019 Feb; 19(2):357-363. PubMed ID: 30661516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race Is an Independent Predictor for Nonroutine Discharges After Spine Surgery for Spinal Intradural/Cord Tumors.
    Elsamadicy AA; Koo AB; David WB; Reeves BC; Freedman IG; Pennington Z; Ehresman J; Kolb L; Laurans M; Shin JH; Sciubba DM
    World Neurosurg; 2021 Jul; 151():e707-e717. PubMed ID: 33940256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The performance of frailty in predictive modeling of short-term outcomes in the surgical management of metastatic tumors to the spine.
    Bakhsheshian J; Shahrestani S; Buser Z; Hah R; Hsieh PC; Liu JC; Wang JC
    Spine J; 2022 Apr; 22(4):605-615. PubMed ID: 34848345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Health Care Resource Utilization After Surgery for Metastatic Spinal Column Tumors in Patients with a Concurrent Affective Disorder in the United States.
    Elsamadicy AA; Koo AB; Sarkozy M; Reeves BC; Pennington Z; Havlik J; Sandhu MR; Hersh A; Patel S; Kolb L; Larry Lo SF; Shin JH; Mendel E; Sciubba DM
    World Neurosurg; 2022 May; 161():e252-e267. PubMed ID: 35123021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of machine learning algorithms for prediction of discharge disposition after elective inpatient surgery for lumbar degenerative disc disorders.
    Karhade AV; Ogink P; Thio Q; Broekman M; Cha T; Gormley WB; Hershman S; Peul WC; Bono CM; Schwab JH
    Neurosurg Focus; 2018 Nov; 45(5):E6. PubMed ID: 30453463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying patients at risk for nonroutine discharge after surgery for cervical myelopathy: an analysis from the Quality Outcomes Database.
    Mummaneni PV; Bydon M; Knightly JJ; Alvi MA; Yolcu YU; Chan AK; Foley KT; Slotkin JR; Potts EA; Shaffrey ME; Shaffrey CI; Fu KM; Wang MY; Park P; Upadhyaya CD; Asher AL; Tumialan L; Bisson EF
    J Neurosurg Spine; 2021 May; 35(1):25-33. PubMed ID: 33962388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tranexamic acid use on venous thromboembolism risk in patients undergoing surgery for spine tumors.
    Pennington Z; Ehresman J; Schilling A; Feghali J; Hersh AM; Hung B; Kalivas EN; Lubelski D; Sciubba DM
    J Neurosurg Spine; 2021 Aug; 35(5):663-673. PubMed ID: 34388705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Frailty Indices and Charlson Comorbidity Index for Predicting Adverse Outcomes in Patients Undergoing Surgery for Spine Metastases: A National Database Analysis.
    Elsamadicy AA; Havlik JL; Reeves B; Sherman J; Koo AB; Pennington Z; Hersh AM; Sandhu MRS; Kolb L; Larry Lo SF; Shin JH; Mendel E; Sciubba DM
    World Neurosurg; 2022 Aug; 164():e1058-e1070. PubMed ID: 35644519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Predictive Models for High-Value Care Outcomes Following Glioblastoma Resection.
    Nair SK; Chakravarti S; Jimenez AE; Botros D; Chiu I; Akbari H; Fox K; Jackson C; Gallia G; Bettegowda C; Weingart J; Mukherjee D
    World Neurosurg; 2022 May; 161():e572-e579. PubMed ID: 35196588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting High-Value Care Outcomes After Surgery for Non-Skull Base Meningiomas.
    Jimenez AE; Chakravarti S; Liu S; Wu E; Wei O; Shah PP; Nair S; Gendreau JL; Porras JL; Azad TD; Jackson CM; Gallia G; Bettegowda C; Weingart J; Brem H; Mukherjee D
    World Neurosurg; 2022 Mar; 159():e130-e138. PubMed ID: 34896348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Frailty on Morbidity and Mortality in Adult Patients Undergoing Surgical Evacuation of Acute Traumatic Subdural Hematoma.
    Elsamadicy AA; Sandhu MRS; Freedman IG; Koo AB; Reeves BC; Yu J; Hengartner A; Havlik J; Hong CS; Rutherford HJV; Kim JA; Gerrard J; Gilmore EJ; Omay SB
    World Neurosurg; 2022 Jun; 162():e251-e263. PubMed ID: 35276399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.